Navigation Links
Study finds more effective treatment for pneumonia following influenza
Date:1/8/2009

adhere to the theory that beta-lactams are the only drugs of choice, because it is necessary to kill the bacteria as fast as possible," he said. "However, our findings represent the first data showing that inflammation is important, and that alternative therapies such as protein synthesis inhibitors should be considered and incorporated into revised guidelines."

More broadly, McCullers said, the new findings support a growing body of evidence that treating severe pneumonia in general should take into account the inflammatory response and not just the rapid demise of bacteria.


'/>"/>

Contact: Carrie Strehlau
carrie.strehlau@stjude.org
901-595-2295
St. Jude Children's Research Hospital
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... September 04, 2015 , ... A Union County charitable ... Core Compassion Project is a non-profit organization dedicated to offering Pilates scholarships to ... cancer treatments and recover their mobility, strength, and range of motion following breast ...
(Date:9/4/2015)... ... September 04, 2015 , ... San Francisco cosmetic dentist ... CEREC is a newer method for creating restorations through innovative imaging equipment and ... the need for multiple appointments, CEREC produces restorations with total precision for a ...
(Date:9/4/2015)... ... September 04, 2015 , ... Many consumers are looking for a quick and convenient way ... , The patent-pending K Med Cups provide a quick and simple way to brew a ... cold, flu or cough. As a result, they enhance comfort and health. The invention features ...
(Date:9/4/2015)... ME (PRWEB) , ... September 04, 2015 , ... ... focus on: the microbiome taking place in Hollywood, Florida October 9-10, 2015 at ... , Speakers at the 2015 symposium are doctors and researchers at the top ...
(Date:9/4/2015)... ... 04, 2015 , ... Lalonde Gordon ran a 44.64 seconds scorcher in the ... the men’s 400 meters final, with an impressive 44.89 seconds at the 2015 North ... Costa Rica in August 2015. The 44.64 time is a new NACAC Championship record. ...
Breaking Medicine News(10 mins):Health News:Girl’s Night Out to Benefit Core Compassion Project, Located at the Beautiful, Morning Glory Farm 2Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3
... women who take combined estrogen/progestin hormone-replacement therapy for ... risk of developing various forms of lobular breast ... Fred Hutchinson Cancer Research Center., Previous research indicated ... use was necessary to increase overall breast-cancer risk, ...
... Jan. 15, 2008 Hormonal components in over-the-counter ... cancer and decrease the effectiveness of anti-cancer drugs, ... , The findings, which appear in todays issue ... patients should inform their doctors about any herbal ...
... feature promotes a more informed health care experience, ... regional studies,indicate that informed patients make better health ... launching a member feedback feature in,Spring 2008 that ... share,information with each other about their provider experiences ...
... Ltd., (Amex: CPD ) announced today that ... final approval for the Company,s,Abbreviated New Drug Application ... and 5/500 mg,(Glipizide/Metformin HCl)., Glipizide/Metformin HCl is ... and exercise, to improve glycemic control in patients ...
... Jan. 14 Three Rivers,Pharmaceuticals, LLC finalized acquisition ... International (NYSE: VRX ). Valeant is,receiving $91 ... "Adding Infergen to our growing portfolio is very ... and chief executive,officer. "This purchase is only a ...
... in Medical Products, Specialty Coatings, ... Transportation and Print Solutions, DETROIT, Jan. ... quarter of 2007 the firm added five companies to its,portfolio, ... completed 14,acquisition and divestiture transactions valued at over $225 million. ...
Cached Medicine News:Health News:Combined HRT increases risk of lobular breast cancer fourfold after just 3 years of use 2Health News:Hormonal dietary supplements might promote prostate cancer progression 2Health News:Hormonal dietary supplements might promote prostate cancer progression 3Health News:Regence Enables Members to Share Feedback With Each Other When Researching Health Care Provider Options 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Metaglip(R) 2Health News:Three Rivers Pharmaceuticals(R), LLC Acquires Hepatitis C Drug Infergen(R) from Valeant Pharmaceuticals 2Health News:Huron Capital Caps Strong Year With Five Acquisitions In 4Q07 2Health News:Huron Capital Caps Strong Year With Five Acquisitions In 4Q07 3
(Date:9/4/2015)... British Columbia and MENLO PARK, ... Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the "Company"), ... of new cancer therapies, today announced its financial results ... provided an overview of recent Company highlights and expected ... host a business update conference call and live webcast ...
(Date:9/3/2015)... 3, 2015 Report Details ... that Market, its R&D and Sales Potentials ... of cancer-treating medicines? Visiongain,s new report gives you revenue predictions ... you discover financial data, R&D trends, opportunities, interviews and revenue ... analysis you see forecasted sales to 2025 at overall world ...
(Date:9/3/2015)... About cardiovascular implants ... or blockage of blood vessels. Cardiac disease is ... cholesterol, and high blood pressure. Coronary artery disease, ... failure are some of the major cardiac diseases. ... coronary arteries, is one of the most common ...
Breaking Medicine Technology:DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 2DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 3DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 4DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 5DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 6DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 7DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 8World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 2World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 3World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 4World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 5World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 6World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 7Global Cardiovascular Implants Market 2015-2019 2
... Maximum Xtra, and Maximum ACT introducers ... and specialty hemostasis introducers in the ... premier hemostasis introducers for use in ... angiography, angioplasty, stenting, atherectomy, temporary pacing, ...
St. Jude Medical's line of guiding introducers includes Swartz Series, SAFL, SEPT, CSTA, RAMP, and 2 piece steerable...
Rapid Exchange Stent Delivery System with Hepacoat...
Curved Tip, 23 Gauge Inner Cannula, Nylon Connector (Also available wtih straight tip) Overall length 60mm; Stainless steel...
Medicine Products: